New CRO unit facility welcomes first overnight patients

Posted:
31
March 2017

Richmond Pharmacology has been busy settling in their first patients at the new London Bridge site.

One month on from Richmond's opening event, which saw leading industry bodies and stakeholders convene, the CRO has been busy settling in their first patients at the new London Bridge site.Clinical work commenced on the 25th March with volunteers commenting on the excellent transport links and fantastic new location in the heart of London Bridge.

Latest news

Upcoming Event

On Helix, Transforming new medicine discovery

13-14 July 2020
Richmond Pharmacology will be showcasing a presentation on Adaptive Early Phase Clinical Trials as part of the ON HELIX digital event.
View event

COVID-19 – External Monitoring Guidelines

July 1, 2020
Richmond Pharmacology is constantly assessing health and safety risks posed by COVID-19 and is regularly reviewing Public Health England guidance.
Read more

First transdermal patch to treat schizophrenia hits market

March 18, 2020
The US Food and Drug Administration (FDA) has officially approved a transdermal patch to treat schizophrenia developed by Hisamitsu Pharmaceutical Co following successful
Read more

Statement: COVID-19

March 23, 2020
Richmond Pharmacology are continuously risk-assessing our activity in relation to the COVID-19 crisis and we are evaluating what activity can continue, what precautions need to be put in place and what needs to be suspended.
Read more